Antimicrobial Resistance Trends of the Most Common Causative Pathogens Associated with Community-acquired Respiratory Infections in China: 2009–2018

References

• Ho J, Ip M. Antibiotic-resistant community-acquired bacterial pneumonia. Infect Dis Clin North Am. 2019;33:1087–1103. doi:10.1016/j.idc.2019.07.002
   PubMed Web of Science ®Google Scholar
• Song J-H, Huh K, Chung DR. Community-acquired pneumonia in the Asia-Pacific region. Semin Respir Crit Care Med. 2016;37:839–854. doi:10.1055/s-0036-1592075
   PubMed Web of Science ®Google Scholar
• Dunne EM, Murad C, Sudigdoadi S, et al. Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children, A cross-sectional study. PLoS One. 2018;13:e0195098. doi:10.1371/journal.pone.0195098
   Web of Science ®Google Scholar
• Hirai J, Kinjo T, Koga T, Haranaga S, Motonaga E, Fujita J. Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults, a retrospective single-centre study. BMC Infect Dis. 2020;20:821. doi:10.1186/s12879-020-05564-9
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45–e67. doi:10.1164/rccm.201908-1581ST
   PubMed Web of Science ®Google Scholar
• Bush K, Bradford PA. β-Lactams and β-Lactamase inhibitors, an overview. Cold Spring Harb Perspect Med. 2016;6:a025247. doi:10.1101/cshperspect.a025247
   PubMed Web of Science ®Google Scholar
• Thakuria B, Lahon K. The beta lactam antibiotics as an empirical therapy in a developing country, an update on their current status and recommendations to counter the resistance against them. J Clin Diagn Res. 2013;7:1207–1214. doi:10.7860/JCDR/2013/5239.3052
   PubMedGoogle Scholar
• Xiao Y. Antimicrobial stewardship in China, systems, actions and future strategies. Clin Infect Dis. 2018;67 suppl_2:S135–S141. doi:10.1093/cid/ciy641
   Web of Science ®Google Scholar
• Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China, results from the CARTIPS antimicrobial surveillance program. J Glob Antimicrob Resist. 2016;5:36–41. doi:10.1016/j.jgar.2016.03.002
   PubMed Web of Science ®Google Scholar
• Wang H, Chen M, Xu Y, et al. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia, report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009–2010. Int J Antimicrob Agents. 2011;38:376–383. doi:10.1016/j.ijantimicag.2011.06.015
   PubMed Web of Science ®Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. 10 Antimicrobial resistance, a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309–318. doi:10.1179/2047773215Y.0000000030
   PubMed Web of Science ®Google Scholar
• Inoue M, Farrell DJ, Kaneko K, et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb Drug Resist. 2008;14:109–117. doi:10.1089/mdr.2008.0806
   PubMed Web of Science ®Google Scholar
• CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved St Andard. 9th ed. CLSI Doc M07-A9. Wayne, PA: Clin Lab Stand Inst; 2012.
   Google Scholar
• Cao B, Huang Y, She D-Y, et al. Diagnosis and treatment of community-acquired pneumonia in adults, 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J. 2018;12:1320–1360. doi:10.1111/crj.12674
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline. 2nd ed. CLSI Doc M45-A2. Wayne, PA: Clinical Lab Stand Inst; 2010.
   Google Scholar
• Khan S, Sallum UW, Zheng X, Nau GJ, Hasan T. Rapid optical determination of β-lactamase and antibiotic activity. BMC Microbiol. 2014;14:84. doi:10.1186/1471-2180-14-84
   Web of Science ®Google Scholar
• Wickham H. ggplot2, Elegant Graphics for Data Analysis. Springer; 2016.
   Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
   PubMed Web of Science ®Google Scholar
• Zhao C, Xie Y, Zhang F, et al. Investigation of antibiotic resistance, serotype distribution, and genetic characteristics of 164 invasive Streptococcus pneumoniae from North China Between April 2016 and October 2017. Infect Drug Resist. 2020;13:2117–2128. doi:10.2147/IDR.S256663
   Web of Science ®Google Scholar
• Zhao C, Li Z, Zhang F, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis. 2017;17:804. doi:10.1186/s12879-017-2880-0
   PubMed Web of Science ®Google Scholar
• Blyth CC, Gerber JS. Macrolides in Children with community-acquired pneumonia, panacea or placebo? J Pediatric Infect Dis Soc. 2018;7:71–77. doi:10.1093/jpids/pix083
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200:E45–67. doi:10.1164/rccm.201908-1581ST
   PubMed Web of Science ®Google Scholar
• Li Y, Tomita H, Lv Y, et al. Molecular characterization of erm(B)- and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010. J Appl Microbiol. 2011;110:254–265. doi:10.1111/j.1365-2672.2010.04875.x
   Web of Science ®Google Scholar
• Tiemei Z, Xiangqun F, Youning L. Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China. Antimicrob Agents Chemother. 2004;48:4040–4041. doi:10.1128/AAC.48.10.4040-4041.2004
   PubMed Web of Science ®Google Scholar
• Berical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal vaccination strategies. an update and perspective. Ann Am Thorac Soc. 2016;13:933–944. doi:10.1513/AnnalsATS.201511-778FR
   PubMed Web of Science ®Google Scholar
• Zheng Y, Rodewald L, Yang J, et al. The landscape of vaccines in China, history, classification, supply, and price. BMC Infect Dis. 2018;18:502. doi:10.1186/s12879-018-3422-0
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang J, Shao X, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study. Vaccine. 2021;39:4620–4627. doi:10.1016/j.vaccine.2021.06.075
   PubMed Web of Science ®Google Scholar
• García-Cobos S, Arroyo M, Pérez-Vázquez M, et al. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem. J Antimicrob Chemother. 2014;69:111–116. doi:10.1093/jac/dkt324
   Web of Science ®Google Scholar